logo

For the Inventor, By the Inventor

Bourg-la-Reine, France

Dieran R Torossian

USPTO Granted Patents = 11

Average Co-Inventor Count = 2.9

ph-index = 4

Forward Citations = 49(Granted Patents)


Location History:

  • Montrouge, FR (1976)
  • Bourg-La-Reine, FR (1977 - 1991)

Company Filing History:

goldMedal8 out of 23 
 
Jouveinal, S.a.
 patents
silverMedal2 out of 2 
 
Sipsy
 patents
bronzeMedal1 out of 1 
 
Societe Industrielle De Produits De Synthese
 patent

Years Active: 1976-1991

Loading Chart...
11 patents (USPTO):Explore Patents
1. 5021408 - Hydrocortisone-17-oxo-21-thioesters, their preparation and their uses as (1991-06-04),
2. 4933331 - Hydrocortisone 17-oxo-21-thioesters and their uses as medicaments (1990-06-12),
3. 4427671 - Steroids esterified in position 17 and thioesterified in position 21, a (1984-01-24),
4. 4301163 - Amino-ether oxides and use thereof in therapy (1981-11-17),
5. 4269778 - Process for the preparation of steroids (1981-05-26),
6. 4177268 - Method of alleviating inflammation by administration of dexamethasone (1979-12-04),
7. 4098804 - Esters of 21-thiol prednisone and prednisolone (1978-07-04),
8. 4098803 - Esters of 21-thiol-steroids hydrocortisone and cortisone (1978-07-04),
9. 4014909 - Esters of 21-thiol steroids (1977-03-29),
10. 3985892 - Pharmaceutical preparation for percutaneous treatment of local edemas (1976-10-12),
11. 3934016 - Pharmaceutical preparation for percutaneous treatment of local edemas (1976-01-20),

Title: Dieran R Torossian: Innovator in Anti-Inflammatory Treatments

Introduction

Dieran R Torossian is an accomplished inventor based in Bourg-la-Reine, France, renowned for his contributions to the field of medicinal chemistry. With a remarkable portfolio of 11 patents, Torossian has focused on developing innovative anti-inflammatory agents that have the potential to significantly impact healthcare.

Latest Patents

Among his noteworthy inventions, Dieran has recently patented compounds such as Hydrocortisone-17-oxo-21-thioesters, including their preparation and uses, specifically as anti-inflammatory medications like 3,20-dione-11.beta.-hydroxypregn-4-ene-21-thioacetate-17-butyrate and 3,20-dione-11.beta.-hydroxypregn-4-ene-21-thiopropionate-17-butyrate. These patents emphasize his dedication to enhancing the therapeutic possibilities of hydrocortisone derivatives.

Career Highlights

Throughout his career, Dieran has worked with notable companies such as Jouveinal S.A. and Sipsy, contributing his expertise in medicinal chemistry and innovation. His extensive experience has enabled him to develop effective pharmaceutical solutions that address inflammatory conditions.

Collaborations

Dieran's impactful work is further enriched by his collaborations with esteemed colleagues, including Gilbert G Aubard and Claude P Roux. These partnerships exemplify the spirit of teamwork that drives progress in the field of medical research.

Conclusion

Dieran R Torossian stands out as a pioneering inventor in the realm of anti-inflammatory therapies. His dedication to innovation, underscored by his numerous patents and collaborative efforts, showcases his significant potential to influence future healthcare advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…